Protective Effect of Lipo-PGE1 on Myocardial Injury Following Percutaneous Coronary Intervention

NCT01245855 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Prostaglandin E1
Percutaneous Coronary Intervention

Interventions

DRUG: lipo-PGE1

Sponsor

First Affiliated Hospital, Sun Yat-Sen University